Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
USPSTF Updates Preventive Aspirin Use Recommendation in CVD, CRC
April 26th 2022There may be a small, but not overwhelming, benefit for certain individuals aged 40 to 59 years who have a slightly elevated risk of future cardiovascular disease (CVD) to start taking aspirin, according to an update released by the US Preventive Services Task Force (USPSTF).
Read More
Use of CSII Linked to Lower Rates of DEB Among Children With T1D
April 23rd 2022This new study investigated and compared the incidence of disordered eating behavior (DEB) among 2 cohorts of patients with type 1 diabetes (T1D) treated with continuous-subcutaneous insulin infusion (CSII) or a basal-bolus regimen.
Read More
Breast MRI Linked to Greater Downstream Service Use, Costs vs Mammography
April 20th 2022This investigation focused on use of additional services and incidence of new diagnoses among women who underwent a breast cancer screening MRI—having a low or average risk of the cancer—compared with a matched cohort who underwent mammography.
Read More
Dr Roxana Siles Discusses Chronic Cough Treatment and Its Adverse Effects
April 20th 2022Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the challenges of treating chronic cough.
Read More
Model Algorithm Demonstrates Effectiveness for T1D Control During Pregnancy
April 19th 2022Investigators fashioned a zone-model predictive controller to evaluate adjustment of closed-loop glycemic control during pregnancy, as both glycemic control and insulin adjustment continually change throughout gestation.
Read More
Long-term Cardiac-Related Mortality Likely Predicted by 30-Day Postsurgical Outcomes
April 18th 2022This study investigated long-term cardiac-related mortality as it relates to incidence of perioperative adverse cardiac events (excluding death) in the first 30 days after surgery among a short of patients who underwent non–cardiac-related surgery.
Read More
Dr Debra Patt Discusses Considering Strategies for Additional COVID-19 Boosters in Breast Cancer
April 16th 2022Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, addresses considerations for getting a second COVID-19 booster, or a fourth dose, among survivors of breast cancer or patients currently undergoing treatment as well as those who may be immunocompromised.
Read More
Experts Explore the Potential of Wearable Tech in T1D Management
April 15th 2022This new literature review explored the potential to enhance management for type 1 diabetes (T1D) through the adoption of physiological parameters measured by wearable and sensor-enabled health-related technology.
Read More
Choice of Breast Cancer Surgical Treatment Likely Influences Long-term QOL
April 13th 2022This new study used data on women with stage 0 to II breast cancer to investigate their long-term quality of life (QOL) as it related to choice of surgery and the decision to undergo adjuvant radiation therapy.
Read More
Dr Roxana Siles: Multispecialty Management of Chronic Cough Maximizes Patient Benefits
April 12th 2022Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the factors that contribute to necessitating multispecialty management of patients with chronic cough.
Read More
AstraZeneca’s Camille Hertzka Addresses rPFS in mCRPC
April 12th 2022Camille Hertzka, vice president, head of oncology, US Medical, AstraZeneca, clarifies testing for the HRR mutation in metastatic castrate-resistant prostate cancer (mCRPC) and the predictive importance of radiographic progression-free survival (rPFS) for overall survival in this setting.
Read More
Mixed QOL Findings Following Treatment Highlight Need for BC Support Services
April 9th 2022This subanalysis of data from the ECOG-ACRIN E5103 trial evaluated longer-term quality of life (QOL) at the 18-month mark among patients with lymph node–positive or high-risk lymph node–negative breast cancer (BC) who have completed active treatment.
Read More
Multidisciplinary, Virtual Endocrinology Care Improves Outcomes in Diabetes
April 8th 2022This new study evaluated the impact of a virtual endocrinology care program on time in range and outcomes among individuals with poorly controlled diabetes who are novice users of continuous glucose monitoring.
Read More
Medicare Must Address High ART Costs, Investigators Argue
April 4th 2022With more people living with HIV now reaching advanced ages and qualifying for Medicare coverage, this new study investigated HIV-related influences on their health care spending, particularly antiretroviral therapy (ART), compared with a population who does not have HIV.
Read More
Algorithm Facilitates Optimal Glycemic Monitoring in New Comparative Study
April 2nd 2022Because type 1 diabetes can be very difficult to effectively manage in children and adolescents, these study investigators compared outcomes between a hybrid closed-loop algorithm add-on and usual care.
Read More
Morbidity, Mortality Improve in HFrEF With Combo Treatment vs Monotherapy
April 2nd 2022This new analysis of data from the Swedish Heart Failure Registry involved an investigation into the relationship between therapy count and dosing on mortality and morbidity among patients with heart failure with reduced ejection fraction (HFrEF).
Read More
AstraZeneca’s Camille Hertzka: Olaparib Could Be Practice Changing
April 1st 2022Camille Hertzka, vice president, head of oncology, US Medical, AstraZeneca, discusses why so much excitement has been generated for the use of olaparib (Lynparza) in the first line for patients with metastatic castrate-resistant prostate cancer.
Read More
Coffee’s Preventive Benefits for CVD, Heart Disease on Display in Study Pair
March 30th 2022Two studies presented at the annual meeting of the American College of Cardiology show the safety and effectiveness of regular coffee consumption in regard to cardiovascular disease and heart disease, as well as mortality.
Read More
Care for Migraine Insufficient in Germany, Online Survey Finds
March 25th 2022An online survey of migraineurs in Germany aimed to evaluate their most pressing unmet needs, with data collected on socioeconomic background, medical care experience, acute medication use, and migraine prophylaxis use and experience.
Read More
HIIT Shown to Improve Cardiometabolic Risk in Heart Failure
March 24th 2022This study enrolled 80 middle-aged patients with stage A heart failure and evaluated them for improvements in several cardiovascular and metabolic risk factors through high-intensity interval training (HIIT) for 1 year and omega-3 fatty acid supplementation.
Read More
MBC Outcomes Superior With Trastuzumab Deruxtecan vs Trastuzumab Emtansine
March 23rd 2022This interim data analysis from the phase 3 DESTINY-Breast03 trial evaluated progression-free survival, overall survival, objective response, and safety between patients with metastatic breast cancer (mBC) progression following previous treatment failure.
Read More